Value proposition

The official LinkedIn page of Terumo Blood and Cell Technologies. Contributing to Society Through Healthcare

Headquartered in Lakewood, Colorado, Terumo Blood and Cell Technologies is a global leader in blood component, therapeutic apheresis and cellular technologies serving customers in more than 130 countries. As the only company with the unique combination of apheresis collections, manual and automated whole blood
processing and pathogen reduction, we believe in the potential of blood to do even more for patients than it does today. This belief unites our organization, inspires our innovation and strengthens our collaboration with customers.

Originally established in 1964 as COBE Laboratories, today, nearly 7,000 associates around the world are deeply committed to our vision of working together for better lives and our promise to unlock the potential of blood and cells. One way we back these words is through our pledge to be a conscientious corporate citizen and conduct our business in a way that provides social, environmental and economic benefit.

At Terumo Blood and Cell Technologies, discovery never stops. We share a passion for thinking in new and different ways and we are proud to support education and research through a variety of community involvement activities as well as by providing grants to advance treatment options for patients. We know the work we do matters and has the potential to fundamentally improve health care. We remain dedicated to ensuring the lifesaving gift of blood is available around the world and to meeting and exceeding the needs of our customers and the patients we ultimately serve.

If you are the best at what you do, we invite you to explore career opportunities with us now!
We have careers in:
• R&D
• IT
• Engineering
• Clinical Sciences
• Manufacturing
• Software Development
• Quality and Regulatory

Social Media Policy: https://www.terumo.com/socialmedia_policy


blood component separation and processing, therapeutic apheresis, cellular technologies, and regenerative medicine